Doctors & patients are saying about 'A-Fib.com'...


"A-Fib.com is a great web site for patients, that is unequaled by anything else out there."

Dr. Douglas L. Packer, MD, FHRS, Mayo Clinic, Rochester, MN

"Jill and I put you and your work in our prayers every night. What you do to help people through this [A-Fib] process is really incredible."

Jill and Steve Douglas, East Troy, WI 

“I really appreciate all the information on your website as it allows me to be a better informed patient and to know what questions to ask my EP. 

Faye Spencer, Boise, ID, April 2017

“I think your site has helped a lot of patients.”

Dr. Hugh G. Calkins, MD  Johns Hopkins,
Baltimore, MD

Front-End Snidget Title


Doctors & patients are saying about 'Beat Your A-Fib'...


"If I had [your book] 10 years ago, it would have saved me 8 years of hell.”

Roy Salmon, Patient, A-Fib Free,
Adelaide, Australia

"This book is incredibly complete and easy-to-understand for anybody. I certainly recommend it for patients who want to know more about atrial fibrillation than what they will learn from doctors...."

Pierre Jaïs, M.D. Professor of Cardiology, Haut-Lévêque Hospital, Bordeaux, France

"Dear Steve, I saw a patient this morning with your book [in hand] and highlights throughout. She loves it and finds it very useful to help her in dealing with atrial fibrillation."

Dr. Wilber Su,
Cavanaugh Heart Center, 
Phoenix, AZ

"...masterful. You managed to combine an encyclopedic compilation of information with the simplicity of presentation that enhances the delivery of the information to the reader. This is not an easy thing to do, but you have been very, very successful at it."

Ira David Levin, heart patient, 
Rome, Italy

"Within the pages of Beat Your A-Fib, Dr. Steve Ryan, PhD, provides a comprehensive guide for persons seeking to find a cure for their Atrial Fibrillation."

Walter Kerwin, MD, Cedars-Sinai Medical Center, Los Angeles, CA


2024 AF Symposium

Spotlight Session: Intranasal Etripamil in AF-RVR: Data on Efficacy for Acute Rate Control (Milestone Pharmaceuticals).

Dr. Jonathan Piccini

Dr. Jonathan Piccini from Duke University Medical Center described a novel nasal medication which could be of major benefit to patients suffering from rapid heart rate Rapid Ventricular Rate (RVR).

Rapid Ventricular Rate is Very Hard on Patients

Rapid Ventricular Rate (RVR) can be very symptomatic, disruptive, and occur far too often for many patients and usually  requires visits to the emergency room (ER). But treatment in the ER often doesn’t work well and is costly both for patients and hospitals.

Etripamil Works to Slow Heart Rate and is Self-Administered

Etripamil is a calcium channel blocker (L type) sprayed into the nose for rapid absorption by the nasal mucosa (soft tissue). It works in only 7 minutes. It slows the heart rate and prolongs the refractory period of the AV Node.

It is administered by the patient themselves outside of a health care facility (such as at home).

Etripamil Safe and Effective

In blind placebo trials Etripamil has been found to be safe and effective in patients with both A-Fib and RVR. It is normally administered if the heart rate goes over 100 beats/minute. The average heart rate reduction was 29.91 beats/minute. It lasts for 150 minutes. There was a very low rate of complications. Most importantly, patient satisfaction was significant.

Editor's CommentsEditor’s Comments
Etripamil Medical Breakthrough! Etripamil is a potential medical breakthrough for patients! Imagine you are having an A-Fib attack where your heart rate goes very high. Instead of running to the ER, you simply spray a medication into your nose which lowers your heart rate by 30% (or more). And it lasts for at least 2 ½ hours.
You now have control over your heart rate which before left you incapacitated, fearful, and feeling terrible. You’re not cured, but at least you can now manage your heart rhythm to a significant extent on your own (at home). You don’t have to rush to your doctor or to a hospital.
Etripamil is a Hopeful Development for A-Fib Patients: Etripamil is probably a long way from getting FDA approval which isn’t guaranteed. But it certainly is a development that is very hopeful for A-Fib patients.
Return to 2024 AF Symposium Reports
If you find any errors on this page, email us. Y  Last updated: Thursday, July 18, 2024

Related Posts

Follow Us
facebook - A-Fib.comtwitter - A-Fib.comlinkedin - A-Fib.compinterest - A-Fib.comYouTube: A-Fib Can be Cured! - A-Fib.com

We Need You Help A-Fib.com be self-supporting-Use our link to Amazon  

A-Fib.com is a
501(c)(3) Nonprofit



Your support is needed. Every donation helps, even just $1.00.


Home | The A-Fib Coach | Help Support A-Fib.com | A-Fib News Archive | Tell Us What You think | Press Room | Candid Seal | HON certification | Disclosures | Terms of Use | Privacy Policy